Overview

Neuroscience is entering a new era, with Brain-on-a-Chip organoids redefining how we model the human brain. Adoption, however, has been slowed by variability, fragile long-term cultures, and the lack of scalable tools for functional readout.

Each challenge is solvable — and the breakthrough lies in moving beyond fragmented fixes toward a unified, integrated platform that delivers mature, reliable organoids at scale, unlocking a new era of precision drug development.

LithopsBio tackles variability, viability, and validation

— removing adoption barriers at scale.

AUTOMATION

Minimize technical
variability and unlock
scalable workflows

MICROFLUIDICS

Enhance oxygenation,
tissue health, and
maturation

MONITORING

Track neural activity
and culture conditions
in real time

Deep-Tech

NIH support has enabled the development of advanced electrophysiology tools that transform “monitoring” from a concept into a scalable reality. These innovations integrate seamlessly with organoid culture systems, providing high‑density, long‑term recordings of neural activity.

Willow | Ultra-high channel count neurophysiology

ASIC | Neurosensing IC

Image 1

MEMS | Silicon probe

Image 2

Validation

Nature logo
Harvard logo MIT Media Lab logo

Article | Published: 26 April 2017

Cell diversity and network dynamics in photosensitive human brain organoids

Giorgia Quadrato, Tuan Nguyen, Evan Z. Macosko, John L. Sherwood, Sung Min Yang, Daniel R. Berger, Natalie Maria, Jorg Scholvin, Melissa Goldman, Justin P. Kinney, Edward S. Boyden, Jeff W. Lichtman, Ziv M. Williams, Steven A. McCarroll & Paola Arlotta

Publications